Research Article

Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still’s Disease

Table 2

Treatments administered after disease onset and at the start of canakinumab. Abbreviations: CAN: canakinumab; cDMARDs: conventional disease-modifying antirheumatic drugs; : number of patients.

(%)

Previous cDMARDs employed
 Methotrexate8 (88.9)
 Hydroxychloroquine3 (33.3)
 Cyclosporine A2 (22.2)
Previous biologics employed
 Anakinra5 (55.6)
 Tocilizumab3 (33.3)
 Adalimumab2 (22.2)
 Etanercept1 (11.1)
Treatments at the start of CAN
 Corticosteroids9 (100)
 cDMARDs (methotrexate)5 (55.6)